REQUEST A DEMO
Total
USD $0.00
Search more companies

Medicenz Pharma Ecza Deposu San. Ve Tic. Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Medicenz Pharma Ecza Deposu Sanayi Ve Ticaret Limited Sirketi Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Medicenz Pharma Ecza Deposu San. Ve Tic. Ltd. Sti. is a company based in Turkiye, with its head office in Ankara. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. 9 (2024) employees currently work for Medicenz Pharma Ecza Deposu San. Ve Tic. Ltd. Sti.. In its most recent financial highlights, the company reported a net sales revenue increase of 21.87% in 2023. Its total assets grew by 409.28% over the same period. The net profit margin of Medicenz Pharma Ecza Deposu San. Ve Tic. Ltd. Sti. decreased by 5.67% in 2023.

Headquarters
No:80 Yeni Baglica Mahallesi Zirve Caddesi Etimesgut
Ankara; Central Anatolia; Postal Code: 06790

Contact Details: Purchase the Medicenz Pharma Ecza Deposu San. Ve Tic. Ltd. Sti. report to view the information.

Website: http://www.medicenz.com

Basic Information
Total Employees:
Purchase the Medicenz Pharma Ecza Deposu San. Ve Tic. Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Medicenz Pharma Ecza Deposu San. Ve Tic. Ltd. Sti. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Medicenz Pharma Ecza Deposu San. Ve Tic. Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
21.87%
Total operating revenue
21.87%
Operating profit (EBIT)
-67.06%
Net Profit (Loss) for the Period
-51.94%
Total assets
409.28%
Total equity
71.46%
Operating Profit Margin (ROS)
-6.81%
Net Profit Margin
-5.67%
Return on Equity (ROE)
-40.34%
Debt to Equity Ratio
12.21%
Quick Ratio
-1.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?